BiotechTube

LY3819253 + Placebo + Remdesivir + VIR-7831 + BRII-196/BRII-198 + AZD7442 + MP0420 + PF-07304814

Phase 3Completed
0 watching 0 views this week๐Ÿ“ˆ Rising
77
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Covid19

Conditions

Covid19

Trial Timeline

Aug 4, 2020 โ†’ Jul 14, 2023

NCT ID
NCT04501978

About LY3819253 + Placebo + Remdesivir + VIR-7831 + BRII-196/BRII-198 + AZD7442 + MP0420 + PF-07304814

LY3819253 + Placebo + Remdesivir + VIR-7831 + BRII-196/BRII-198 + AZD7442 + MP0420 + PF-07304814 is a phase 3 stage product being developed by Eli Lilly for Covid19. The current trial status is completed. This product is registered under clinical trial identifier NCT04501978. Target conditions include Covid19.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT04501978Phase 3Completed

Competing Products

20 competing products in Covid19

See all competitors
ProductCompanyStageHype Score
Favipiravir + NitazoxanideStrides PharmaPhase 2
51
Icosapent ethylAmarin CorporationApproved
77
GX-03 + Petrolatum ointmentTurn TherapeuticsPhase 2
44
Cytotoxic T LymphocytesTevogen BioPhase 1
25
DS-5670a + PlaceboDaiichi SankyoPhase 1/2
41
Pegylated Interferon-ฮฑ2bZydus LifesciencesPhase 2
52
BaricitinibEli LillyPhase 3
77
bamlanivimabEli LillyApproved
85
1x10^9 vp AZD1222 + 5x10^9 vp AZD1222 + 1x10^10 vp AZD1222AstraZenecaPhase 1
33
Sacubitril / Valsartan Oral Tablet [Entresto] + PlaceboNovartisPhase 1/2
41
PirfenidoneRochePre-clinical
23
Remdesivir + Remdesivir Placebo + CorticosteroidGilead SciencesPhase 3
76
RemdesivirGilead SciencesPre-clinical
22
Remdesivir + Remdesivir Placebo + Aviptadil + Aviptadil Placebo + CorticosteroidGilead SciencesPhase 3
76
anti-COVID19 mRNA-based vaccine (BNT162b2, Comirnatyยฎ, commercialized by Pfizer)PfizerPhase 3
76
Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine + CoronaVac COVID-19 vaccine + ChAdOx1 nCoV-19 Covid-19 Vaccine + Ad26.COV2.S COVID-19 VaccinePfizerPre-clinical
22
Tofacitinib 10 mg + PlaceboPfizerPhase 3
76
BNT162b2PfizerPhase 2
51
Anakinra + 0.9% SalineSwedish Orphan BiovitrumPhase 2
51
COVID-19 vaccine Pfizer (3 doses) + COVID-19 vaccine Pfizer (2 doses) + COVID-19 mRNA Vaccine Moderna (3 doses) + COVID-19 mRNA Vaccine Moderna (2 doses) + COVID-19 mRNA Vaccine Moderna (1 dose)SanofiApproved
84

Other Products from Eli Lilly

Insulin Glargine + Insulin Lispro Premix (mid-mixture and low-mixture)Approved
85
Olanzapine + PlaceboApproved
85
exenatide and sitagliptin + exenatide and placeboApproved
85
Tirzepatide + PlaceboApproved
85
tadalafilApproved
85